The biggest difference between a weight loss pill and a weekly injection comes down to absorption (bioavailability)
Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) showing promising early evidence for significant weight reduction, improved metabolic markers, and reduced liver fat, but it has not yet received MHRA or EMA approval
In this trial, at 60 weeks, the exenatide group showed a significant improvement in MDS-UPDRS Part III scores compared to the placebo group among the 62 recruited patients (80)
Neurotherapeutics 16 , 611634 (2019)
Country of Origin:USA Manufacturer/Importer/Packed By:Supergut
The medication begins working within days after injection, with peak plasma concentrations typically reached within one to three days